So two large clinical studies concluded that this antibody drug does not work. Nevertheless, FDA approved drug and Biogen stock went up.

Aren't we just a bunch of greedy monkeys?

PS: Therapy costs $56,000/year. My question stands.

PPS: Seems like Medicare will pay for it, so burden is on taxpayers.